A5056556000- Tuberculosis Research and Epidemiology
- Viral Infections and Outbreaks Research
- Infectious Diseases and Tuberculosis
- Global Maternal and Child Health
- Mycobacterium research and diagnosis
- Food Security and Health in Diverse Populations
- Human Rights and Development
- COVID-19 and healthcare impacts
- Pneumonia and Respiratory Infections
- Interpreting and Communication in Healthcare
- African Sexualities and LGBTQ+ Issues
- Healthcare cost, quality, practices
- HIV, Drug Use, Sexual Risk
- Child Nutrition and Water Access
- Schizophrenia research and treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Chronic Disease Management Strategies
- HIV/AIDS Impact and Responses
Facility-based directly observed therapy (DOT) has been the standard for treating people with TB since early 1990s. As commitment to promote a people-centred model of care grows, use facility-based DOT questioned as issues freedom, privacy, and human rights have raised. The disruptions caused by COVID-19 pandemic ensuing lockdown measures fast-tracked need find alternative methods provide treatment TB. In this study, we present quantitative qualitative findings from global community-based...
Sectors beyond health are essential to combatting a social disease such as tuberculosis (TB). The engagement of the community and civil society sector in Eastern Europe Central Asia was assessed part broader baseline assessment multisectoral national TB responses. This mixed-methods community-based study. Surveys, interviews, focus groups were conducted online with TB-engaged representatives Belarus, Kazakhstan, Moldova, Tajikistan, Ukraine from January June 2021. Quantitative data, analyzed...
Tuberculosis (TB) is an infectious disease closely intertwined with stigma, discrimination, and the social determinants of health. Communities people affected by TB are experts in their care pathways, but field continues to fall short meaningfully engaging communities research. This a missed opportunity improve quality, relevance, person-centeredness, positive impact, sustainability research outputs. We acknowledge important progress that has been made date regarding community engagement TB,...
Until COVID-19, tuberculosis (TB) was the leading infectious disease killer globally, disproportionally affecting people with HIV. The COVID-19 pandemic is threatening gains made in fight against both diseases.